These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9344045)

  • 1. Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.
    Shibata K; Kikkawa F; Nawa A; Tamakoshi K; Suganuma N; Tomoda Y
    Clin Exp Metastasis; 1997 Nov; 15(6):612-9. PubMed ID: 9344045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines.
    Shibata K; Kikkawa F; Nawa A; Suganuma N; Hamaguchi M
    Cancer Res; 1997 Dec; 57(23):5416-20. PubMed ID: 9393769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The different stimulatory effect of normal tissues on the secretion of matrix metalloproteinases and their inhibitors by human ovarian cancer cells.
    Kikkawa F; Nawa A; Shibata K; Obata NH; Tamakoshi K; Suzuki S; Mizutani S
    Anticancer Res; 1998; 18(6A):4323-8. PubMed ID: 9891486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
    Kikkawa F
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of Peritoneal Mesothelial Cells to Secrete Matrix Metalloproteinase-9 (MMP-9) by TNF-α: A Role in the Invasion of Gastric Carcinoma Cells.
    Oku T; Shimada K; Kenmotsu H; Ando Y; Kurisaka C; Sano R; Tsuiji M; Hasegawa S; Fukui T; Tsuji T
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells].
    Zhang JJ; Wang B
    Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
    Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
    Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases-2 and -9 by cells isolated from the peritoneal fluid of women with ovarian carcinoma.
    Sakata K; Shigemasa K; Uebaba Y; Nagai N; Ohama K
    Acta Cytol; 2002; 46(4):697-703. PubMed ID: 12146034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
    Fishman DA; Bafetti LM; Stack MS
    Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells.
    Rougier JP; Moullier P; Piedagnel R; Ronco PM
    Kidney Int; 1997 Jan; 51(1):337-47. PubMed ID: 8995752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues.
    Kikkawa F; Tamakoshi K; Nawa A; Shibata K; Yamagata S; Yamagata T; Suganuma N
    Cancer Lett; 1997 Nov; 120(1):109-15. PubMed ID: 9570393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
    Zhang J; Wang B
    Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells.
    Fishman DA; Bafetti LM; Banionis S; Kearns AS; Chilukuri K; Stack MS
    Cancer; 1997 Oct; 80(8):1457-63. PubMed ID: 9338470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesothelial vitronectin stimulates migration of ovarian cancer cells.
    Heyman L; Leroy-Dudal J; Fernandes J; Seyer D; Dutoit S; Carreiras F
    Cell Biol Int; 2010 Apr; 34(5):493-502. PubMed ID: 20121701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.
    Rao VH; Singh RK; Bridge JA; Neff JR; Schaefer GB; Delimont DC; Dunn CM; Sanger WG; Buehler BA; Sawaya R; Nicolson GL; Rao JS
    Clin Exp Metastasis; 1997 Jul; 15(4):400-9. PubMed ID: 9219728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
    Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.
    Rougier JP; Guia S; Hagège J; Nguyen G; Ronco PM
    Kidney Int; 1998 Jul; 54(1):87-98. PubMed ID: 9648067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2).
    Westerlund A; Hujanen E; Puistola U; Turpeenniemi-Hujanen T
    Gynecol Oncol; 1997 Oct; 67(1):76-82. PubMed ID: 9345360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
    Tamakoshi K; Kikkawa F; Nawa A; Ishikawa H; Mizuno K; Tamakoshi A; Yamagata S; Suganuma N; Tomoda Y
    Cancer; 1995 Dec; 76(12):2565-71. PubMed ID: 8625086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.